The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Danilova T.V.

Kazan State Medical University;
Interregional Clinical Diagnostic Center

Iksanova A.G.

Kazan Federal University

Khasanova D.R.

Kazan State Medical University

Multimodal action of the drug Dimephosphon for the normalization of autonomic homeostasis

Authors:

Danilova T.V., Iksanova A.G., Khasanova D.R.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(5): 34‑43

DOI: 10.17116/jnevro202512505134

Read: 1038 times

Buy for 300₽
Contact the author
Table of contents

MULTIMODAL ACTION OF THE DRUG DIMEPHOSPHON FOR THE NORMALIZATION OF AUTONOMIC HOMEOSTASIS
MULTIMODAL ACTION OF THE DRUG DIMEPHOSPHON FOR THE NORMALIZATION OF AUTONOMIC HOMEOSTASIS

To cite this article:

Danilova TV, Iksanova AG, Khasanova DR. Multimodal action of the drug Dimephosphon for the normalization of autonomic homeostasis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(5):34‑43. (In Russ.)
https://doi.org/10.17116/jnevro202512505134

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
The pote­ntial of cortical electrical stimulation for the study of auto­nomic dysfunction in patients with epilepsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):25-34
Pathogenetic aspe­cts of the effe­cts of changes in the geomagnetic field on the vege­tative regu­lation and the risk of vascular diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):145-150
Improving an auto­matic stress test analysis protocol as a problem solu­tion for sympatho-dependent arrhythmias identification. Russian Journal of Preventive Medi­cine. 2024;(11):115-121
Effect of narcotic analgesics on postoperative vege­tative tone in children. Russian Journal of Pain. 2025;(1):34-37
Sore throat and panic atta­cks: is a rela­tionship possible? Clinical example. Russian Bulletin of Otorhinolaryngology. 2025;(2):69-73
Abstract:

This review article presents the spectrum of pharmacological action and aspects of clinical application of the original domestic drug Dimephosphon (international nonproprietary name — dimethyl oxobutylphosphonyl dimethylate) based on a significant number of sources. The article reflects the results of experimental and clinical studies on the efficacy and safety of Dimephosphon, indicating its multimodal action and the possibility of using the drug as a means for normalizing autonomic homeostasis.

Keywords:

Dimephosphon
autonomic nervous system
adaptogen

Authors:

Danilova T.V.

Kazan State Medical University;
Interregional Clinical Diagnostic Center

Iksanova A.G.

Kazan Federal University

Khasanova D.R.

Kazan State Medical University

Received:

11.04.2025

Accepted:

16.05.2025

Close metadata

References:

  1. Vein AM. Vegetative disorders: Clinic. Treatment. Diagnostics. M.: Med. inform. agency, 2003. 752 p. (In Russ.).
  2. Ermolaeva AI, Baranova GA. Autonomic nervous system and autonomic disorders. Penza: Penza State Medical Institute, 2015. 39 p. (In Russ.).
  3. Reutov VP, Chertok VM. New ideas about the role of the autonomic nervous system and nitric oxide generation systems in the brain vessels. Pacific Medical Journal. 2016;2:10-19 (In Russ.).
  4. Baker JR, Hira R, Uppal J, et al. Clinical Assessment of the Autonomic Nervous System. Card Electrophysiol Clin. 2024;16(3):239-248.  https://doi.org/10.1016/j.ccep.2024.02.001
  5. Roche F, Pichot V, Mouhli-Gasmi L, et al. Anatomy and physiology of the autonomic nervous system: Implication on the choice of diagnostic/monitoring tools in 2023. Revue Neurologique (Paris). 2024;180(1-2):42-52.  https://doi.org/10.1016/j.neurol.2023.12.003
  6. Anokhin PK. Theory of the functional system. M.: Nauka, 1980. 460 p. (In Russ.).
  7. Basantsova NYu, Tibekina LM, Shishkin AN. A role of the autonomic nervous system in cerebro-cardiac disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(11):153-160. (In Russ.). https://doi.org/10.17116/jnevro2017117111153-160
  8. De Morree HM, Szabó BM, Rutten GJ, et al. Central nervous system involvement in the autonomic responses to psychological distress. Netherlands Heart Journal. 2013;21:64-69.  https://doi.org/10.1007/s12471-012-0351-1
  9. Quade BN, Parker MD, Occhipinti R. The therapeutic importance of acid-base balance. Biochemical Pharmacology. 2021;183:114278. https://doi.org/10.1016/j.bcp.2020.114278
  10. Zhang S, Sun P, Sun Z, et al. Cortical GABAergic neurons are more severely impaired by alkalosis than acidosis. BMC Neurology. 2013;13:192.  https://doi.org/10.1186/1471-2377-13-192
  11. Basting TM, Burke PGR, Kanbar R, et al. Hypoxia silences retrotrapezoid nucleus respiratory chemoreceptors via alkalosis. The Journal of Neuroscience. 2015;35(2):527-543.  https://doi.org/10.1523/JNEUROSCI.2923-14.2015
  12. Bogoyavlensky VF, Medvedev NP, Abdrakhmanova RSh. Acid-base balance and its changes in some diseases. Kazan Medical Journal. 1971;52(3):1-8. (In Russ.).
  13. Alliluyev IA. Transcription factor HIF-1: mechanisms of regulation during hypoxia and normoxia. News of higher educational institutions North Caucasus region Natural sciences. 2014;3(181):56-60. (In Russ.).
  14. Slepneva LV, Khmylova GA. Mechanism of damage to energy metabolism during hypoxia and possible ways of its correction with fumarate-containing solutions. Transfusiology. 2013;14(2):49-65. (In Russ.).
  15. Smirnov AV, Gorelik EV, Grigorieva NV, et al. Morphofunctional mechanisms of neuronal damage in cerebral ischemia. Volgograd Scientific Medical Journal. 2022;1:5-10. (In Russ.).
  16. Litvitskii PF. General Etiology of Nervous Activity Disturbances. Neurogenic Pathological Syndromes. Issues of modern pediatrics. 2013;12(4):73-90. (In Russ.). https://doi.org/10.15690/vsp.v12i4.734
  17. Aminova LR, Siddiq A, Ratan RR. Antioxidants, HIF prolyl hydroxylase inhibitors or short interfering RNAs to BNIP3 or PUMA, can prevent prodeath effects of the transcriptional activator, HIF-1alpha, in a mouse hippocampal neuronal line. Antioxidants & Redox signaling, 2008;10(12):1989-1998. https://doi.org/10.1089/ars.2008.2039
  18. Liu J, Wei E, Wei J, et al. MiR-126-HMGB1-HIF-1 Axis Regulates Endothelial Cell Inflammation during Exposure to Hypoxia-Acidosis. Disease Markers. 2021;4933194. https://doi.org/10.1155/2021/4933194
  19. Dumansky YuV, Kabanova NV, Verkhuletsky IE, et al. Methods of diagnostics and correction of water-electrolyte metabolism and acid-base balance disorders. Emergency Medicine. 2011;7-8(38-39):175-190. (In Russ.).
  20. Ischemic stroke and transient ischemic attack in adults. Clinical guidelines. M.: Ministry of Health of the Russian Federation. 2024. The link is active on 03/07/2025. (In Russ.). https://cr.minzdrav.gov.ru/preview-cr/814_1
  21. Basantsova NYu, Shishkin AN, Tibekina LM. Cerebral-cardiac syndrome and its manifestation after acute stroke. Vestnik SPbSU. Medicine, 2017;12(1):31-47. (In Russ.). https://doi.org/10.21638/11701/spbu11.2017.103
  22. Koryachkin VA, Strashnov VI. Intensive therapy of life-threatening conditions. St. Petersburg Medical Publishing House, 2002. 288 p. (In Russ.).
  23. Utkin SI. Methodology for correcting metabolic acidosis in patients with alcohol withdrawal syndrome with delirium using the drug dimethyl oxobutylphosphonyl dimethylate (Dimephosphone). M.: Scientific and Practical Center for Narcology. 2022. 20 p. (In Russ.).
  24. Instructions for medical use of the drug Dimephosphon®, concentrate for the preparation of a solution for intravenous administration (JSC Tatchempharmpreparaty, LP-003523). State Register of Medicines. (In Russ.). The link is active on 03/07/2025. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=59ab039c-7513-40a6-8e1d-1e0587e9f86a
  25. Maximov ML, Malykhina AI, Shikaleva AA. Time-proved pharmacotherapy: from mechanisms to clinical efficacy. RMJ. 2020;9:71-76. (In Russ.).
  26. Vizel AA. Dimephosphone. Application in pulmonology. Polyclinic. 2008; 5:82-84. (In Russ.).
  27. Mironov VF, Buzykin BI, Tatarinov DA, et al. Dimephosphone analogs: a pharmacological aspect. Proceedings of the Academy of Sciences. The Chemical Series. 2014;63(9):2114-2125. (In Russ.).
  28. Ziganshina LE, Studentova IA, Ziganshin AU, et al. Mechanism of action of dimephosphone. Experimental and Clinical Pharmacology. 1992;55(2):43-45. (In Russ.).
  29. Perfilieva NP, Ipastova ID. Neurotoxic effect of dimephosphone on the rat cerebellum. Bulletin of the Ulyanovsk State Agricultural Academy. 2014;1(25):5-58. (In Russ.).
  30. Ipastova ID, Perfil’eva NP. On the influence of dimephosphone on the morphology of the cerebellum of a white rat. Bulletin of Bryansk State University. Exact and natural sciences. 2014;4:83-88. (In Russ.).
  31. Malyshev VG, Fedoseikin IV. Effect of dimephosphone on the body’s homeostasis. Moscow: Nauka, 2007. 215 p. (In Russ.).
  32. Belova YuA, Kotov SV. Antioxidant therapy in complex treatment of patients with ischemic stroke in the acute and recovery period. Neurology, Neuropsychiatry, Psychosomatics. 2023;15(2):120-125. (In Russ.). https://doi.org/10.14412/2074-2711-2023-2-120-125
  33. Belova YuA, Kotov SV. Study of the efficacy and safety of dimethyloxobutylphosphonyldimethylate in complex therapy of patients with the consequences of ischemic stroke. Consilium Medicum. 2021;23(2):127-130. (In Russ.).
  34. Ziganshina LE, Studentsova IA, Zaikonnikova IV. Effect of dimephosphone on exudation and proliferation processes. Pharmacology and Toxicology. 1999;53(1):57-59. (In Russ.).
  35. Pratsuk SA, Khafizyanova RKh, Borodin YuI. Pharmacotherapy of chronic placental insufficiency. Kazan Medical Journal. 2003;6:443-446. (In Russ.).
  36. Bulatov VP. Use of Dimephosphone in Pediatrics. Scientific Review of Clinical Studies. Polyclinic. 2009;(1):129-131. (In Russ.).
  37. Andreevich VA, Oskarovich VA, Shchukina LI. Dimephosphone: application in pulmonology and phthisiology. Atmosphere. Pulmonology and Allergology. 2013;(3):40-44. (In Russ.).
  38. Poluektov MG, Podymova IG, Golubev VL. Potentials of Using Dimephosphone in Neurology and Neurosurgery. Doctor.Ru. 2015;5(106)-6(107):5-10 (In Russ.).
  39. Khuzina GR, Zakirova DR. Clinical effects of medication “Dimephosphon” in case of posttraumatic encepholopathy: clinical, neuropsychological and MR-tomography. Modern Medicine. Neurology/Psychiatry. 2016;1(1):7-11 (In Russ.).
  40. Zakirova DR, Khuzina GR, Mamedov HI, et al. Neuroprotective therapy for chronic brain ischemia: clinical effects of the drug Dimephosphon. Modern medicine. 2018;1(9):55-60 (In Russ.).
  41. Chuyan EN, Ravayeva MY, Nefedov DA, et al. Dimephosphon effects on skin microhaemodynamics. Kuban Scientific Medical Bulletin. 2017; 24(5):90-95. (In Russ., English abstract). https://doi.org/10.25207/1608-6228-2017-24-5-90-95
  42. Dikova OV. Effect of dimephosphone in combination with negative oxygen aeroions on the clinical course and some homeostasis indices of patients with eczema. Bulletin of New Medical Technologies. 2008; 15(2):87. (In Russ.).
  43. Zlatkovskaya MV, Gatin FF, Yusupova LA, et al. Results of using dimephosphone in the complex therapy of patients with schizophrenia with concomitant pustular skin diseases. Neurological Bulletin. 2009;41(2):24-28. (In Russ.).
  44. Ostrovskaya VF. Use of dimephosphone in the complex treatment of patients with generalized periodontitis of moderate severity. Transbaikal Medical Bulletin. 2007;(3):13-15. (In Russ.).
  45. Fonnum F, Lock EA. Cerebellum as a target for toxic substances. Toxicol Lett. 2000;112-113:9-16.  https://doi.org/10.1016/s0378-4274(99)00246-5
  46. Hazarika R. Neurotoxic impact of organophosphate pesticide phosphomedon on the albino rat. J Env Biol. 2014;35(2):427-430. 
  47. Mehl A, Schanke TM, Torvik A, et al. The effect of trichlorfon and methylazoxymethanol on the development of guinea pig cerebellum. Toxicol Appl Pharmacol. 2007; 219(2-3):128-135.  https://doi.org/10.1016/j.taap.2006.10.024
  48. Ramezani A, Goudarzi I, Lashkarboluki T, et al. Role of oxidative stress in ethanol-induced neurotoxicity in the developing cerebellum. Iran J Bas Med Sci. 2012;15(4):965-974. 
  49. Malyshev VG, Fedoseikin IV. Use of dimephosphone in medicine. Moscow: Nauka. 2008. (In Russ.).
  50. Studentsova IA, Ziganshin AU, Valeeva IH. Mechanism of a dimephosphon action. Expert and Clinical Pharmacology. 1992;53(2):43-45. (In Russ.).
  51. Studentsova IA, Danilov VI, Khafizyanova RKh. Results of clinical testing of dimephosphone as a vasoactive agent normalizing functions of the nervous system. Kazan Medical Journal. 1995;76(5):214-218. (In Russ.).
  52. Anchikova LI, Valeeva IKh, Pozdnyak AO, et al. On the mechanism of antiacidotic action of dimephosphone. Kazan Medical Journal. 1988;69(5):362-364. In Russ.). https://doi.org/10.17816/kazmj98457
  53. Anchikova LI, Valeeva IKh, Studentsova IA. To the mechanism of action of the domestic drug Dimephosphone. Kazanskiy Meditsinskiy Zhurnal. 2005;86(2):92-97. (In Russ.).
  54. Tsibulkina VN, Kostin YaV, Shmyreva NV. Study of the main mechanisms of action of dimephosphone on the model of stimulated aggregation of human platelets. Medicine. 2000:106-109. (In Russ.).
  55. Tsibulkina VN. Leading mechanisms of the therapeutic action of dimephosphone. Kazanskiy Meditsinskiy Zhurnal. 1999; 2:120-122. (In Russ.).
  56. Valeeva IH, Ziganshina LE, Burnashova ZA, et al. Dimephosphone and xydiphone effect on the indexes of lipid peroxidation and antioxidant system of rats which received prednisolone for a long time. Experim and Clin Pharmacology. 2002;2:40-43. (In Russ.).
  57. Vizel AO, Garayev RS. A new aspect of the pharmacological approach to phosphorus compounds. Dimephosphon. Kazan: Pechat-servis-XXI century, 2012. 189 p. (In Russ.).
  58. Danilov VI, Studentsova IA. Dimephosphon drug of choice in diseases of nervous system. Neurology. Terra Medica. 2000;1:34-35 (In Russ.).
  59. Ismagilov MF. Cerebral vegetative disorders of the pubertal period: Diss. … Doctor of Medicine. Kazan, 1986. 440 p. (In Russ.).
  60. Ismagilov MF. Vegetative constitution, cardiac balance, autonomic nervous system, syndromes of autonomic dysfunction. Neurological Bulletin. 2014; XLVI(4):91-96. (In Russ.).
  61. Danilov VI, Gorozhanin AV. Study of Dimephosphone on the cerebral circulation regulation system in patients with brain tumors. Burdenko’s Journal of Neurosurgery. 1994;2:23-26. (In Russ.).
  62. Danilov VI, Pankova VP, Studentsova IA, et al. Experimental and clinical substantiation of the use of Dimephosphone in surgical and craniocerebral injuries. Neurosurgery. 2002;2:43-48. (In Russ.).
  63. Dzhordzhikiya RK, Khasanova DR, Valeev RR, et al. The state of the autonomic nervous system in children with congenital heart defects of the pale type, operated on under artificial circulation. Children’s Diseases of the Heart and Blood Vessels. 2005;6:64-68. (In Russ.).
  64. Medvedev VN, Khasanova DR, Vergasov EA, et al. The state of vegetative regulation in children with congenital heart defects of the pale type. Neurological Bulletin. 1999; 31(1-4)45-48. (In Russ.). https://doi.org/10.17816/nb80929
  65. Yakupova SP, Ismagilov MF, Salikhov JG. Vegetative nervous system disfunction in patients with rheumatoid arthritis and possibility of its correction with dimephosphonum. Neurological Bulletin. 2000;32(3-4):28-31. (In Russ.). https://doi.org/10.17816/nb79477
  66. Gilyalov MN, Ismagilov ShM. Vegetotropic therapy in the complex treatment of patients with rhinosinusitis. Practical Medicine. 2015;4(2):30-32. (In Russ.).
  67. Gilyalov MN, Ismagilov ShM, Ismagilov MF. Complex therapy of patients with rhinosinusitis, taking into account the characteristics of the vegetative status. Practical Medicine. 2016;4(2(96)):36-38. (In Russ.).
  68. Danilin VG, Kapitonenko AM. Experience of Dimephosphone Treatment of Patients with Ischemic Stroke and Atherosclerotic Discirculatory Encephalopathy. Abstract of the report of the Russian Conf., dedicated to the 75th anniversary of I.V. Zaikonnikova: Pharmacology and Toxicology of Organophosphorus and Other Biologically Active Substances. Kazan, 1996;3:47. (In Russ.).
  69. Poluektov MG, Podymova IG, Golubev VL. Experience of using dimephosphone in the treatment of non-motor manifestations of cerebrovascular insufficiency. Practical Medicine. 2015;5(90):164-168. (In Russ.).
  70. Khuzina GR, Mamedov HI, Zakirova DR, Sitdikova AI. Use of the drug «Dimephosphone» in the complex therapy of patients who suffered cerebellar infarction in the pool of the posterior inferior cerebellar artery. Modern medicine. 2017;1(5):2-7. (In Russ.).
  71. Zolotarev OV, Dorokhov EV, Yakovlev VN. Dysfunction of the autonomic nervous system in ischemic strokes of the brainstem and hemispheric localization. Journal of Theoretical and Practical Medicine. 2004;3(2):34-37. (In Russ.).
  72. Brodie FG, Panerai RB, Foster S, et al. Long term changes in dynamic cerebral autoregulation: a 10 years follow up study. Clin Physiol Funct Imaging. 2009;29(5):366-371.  https://doi.org/10.1111/j.1475-097X.2009.00880.x
  73. Danilova TV, Knni KS, Magsumova RL, et al. The efficacy of the anti-acidemic agent dimephosphone at the first rehabilitation stage in patients in the acute period of carotid-related ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(3):44-51. (In Russ.). https://doi.org/10.17116/jnevro202112103144
  74. Burykin IM, Aleeva GN, Khafizyanova RKh. Introduction of Dimephosphone in early pregnancy and evaluation of its effect on the offspring of rats. Experimental and Clinical Pharmacology. 2004;67(2):35-37 (In Russ.).
  75. Gusev AB, Yurevich MA. The sovereignty of Russia in the area of pharmaceuticals: Challenges and opportunities. Terra Economicus. 2023;21(3):17-31. (In Russ.). https://doi.org/10.18522/2073-6606-2023-21-3-17-31
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.